Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr2.64 SEK
Change Today +0.04 / 1.54%
Volume 55.5K
GTABB On Other Exchanges
Symbol
Exchange
Nordic GM
As of 7:41 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

glycorex transplantation-b (GTABB) Snapshot

Open
kr2.51
Previous Close
kr2.60
Day High
kr2.64
Day Low
kr2.50
52 Week High
09/8/14 - kr3.39
52 Week Low
12/17/14 - kr2.00
Market Cap
160.5M
Average Volume 10 Days
30.5K
EPS TTM
kr-0.08
Shares Outstanding
57.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GLYCOREX TRANSPLANTATION-B (GTABB)

Related News

No related news articles were found.

glycorex transplantation-b (GTABB) Related Businessweek News

No Related Businessweek News Found

glycorex transplantation-b (GTABB) Details

Glycorex Transplantation AB (publ) engages in the research, development, production, and sale of medical devices in the field of organ transplantation. The company’s principal product includes Glycosorb-ABO, a medical device, which facilitates transplantations regardless of the blood types in donors and recipients. The Glycosorb-ABO is used in the transplantation of kidney, liver, heart, combined kidney/pancreas, lung, bone marrow, and stem cells. The company offers its product to hospitals and pharmaceutical companies in Europe, Australia, India, Canada, Turkey, Singapore, Cyprus, Malaysia, and Israel. Glycorex Transplantation AB (publ) is headquartered in Lund, Sweden.

glycorex transplantation-b (GTABB) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr196.0K
Founder, Vice-President and Director
Total Annual Compensation: kr870.0K
Compensation as of Fiscal Year 2013.

glycorex transplantation-b (GTABB) Key Developments

Glycorex Transplantation AB (publ), Annual General Meeting, Jun 05, 2014

Glycorex Transplantation AB (publ), Annual General Meeting, Jun 05, 2014.

Glycorex Transplantation AB (publ) to Report First Half, 2014 Results on Aug 22, 2014

Glycorex Transplantation AB (publ) announced that they will report first half, 2014 results on Aug 22, 2014

Glycorex Transplantation AB (publ) to Report Fiscal Year 2013 Results on Apr 30, 2014

Glycorex Transplantation AB (publ) announced that they will report fiscal year 2013 results on Apr 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTABB:SS kr2.64 SEK +0.04

GTABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTABB.
View Industry Companies
 

Industry Analysis

GTABB

Industry Average

Valuation GTABB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.6x
Price/Book 2.4x
Price/Cash Flow 228.2x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLYCOREX TRANSPLANTATION-B, please visit www.glycorex.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.